Benztropine Mesylate Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Benztropine Mesylate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Jan 27, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
63323-970-02
Dosage Form
Injection
Presentation
Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
Initial Posting
Jan 27, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.